大洋生物公告称，2025年12月11日，公司第六届董事会第八次会议审议通过新建年产2000吨特种高分子 材料聚醚醚酮（PEEK）及关键中间体4,4′–二氟二苯甲酮等项目的议案，尚需股东会审议。项目总投资 1.9325亿元，资金来自自有资金及银行融资，建设周期30个月，地点在建德市高新技术产业园大洋区 块。该项目可打破海外产业链封锁，填补市场产能缺口。公司提示了市场、技术、成本等风险。 ...

证券代码：003017 证券简称：大洋生物 公告编号：2025-102 浙江大洋生物科技集团股份有限公司 关于召开 2026 年第一次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈 述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2026 年第一次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票 上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运 作》等法律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。 4、会议时间： （1）现场会议时间：2026 年 01 月 09 日 14:00 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2026 年 01 月 09 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投 票系统投票的具体时间为 2026 年 01 月 09 日 9:15 至 15:00 的任意时间。 5、会议的召开方式：现场表决与网络投票相结合。 6、会议的股权登记日：202 ...

证券代码：003017 证券简称：大洋生物 公告编号：2025-098 浙江大洋生物科技集团股份有限公司 第六届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江大洋生物科技集团股份有限公司（以下简称"公司"或"本公司"）第 六届董事会第八次会议于2025年12月11日以现场形式召开，会议通知已于2025 年 12 月 5 日以书面或电子邮件方式发出。本次会议由公司董事长陈阳贵先生主 持，会议应出席的董事 9 人，实际出席的董事 9 人。公司高级管理人员列席。本 次会议的通知、召集和召开符合《公司法》等有关法律、行政法规、部门规章、 规范性文件和《公司章程》的有关规定，合法有效。 二、董事会会议审议情况 本议案经董事会提名委员会审议通过。 2.议案表决结果：同意 9 票；反对 0 票；弃权 0 票。 （二）审议通过《关于公司部分募投项目延期完成的议案》 1.议案内容：为保证项目的顺利实施，综合考虑当前市场环境、现有产能利 用情况等因素，公司放缓了募投项目的建设投入进度，因此公司在项目的实施主 体、实施方式均未 ...

证券代码：003017 股票简称：大洋生物 公告编号：2025-097 浙江大洋生物科技集团股份有限公司 并继续进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 浙江大洋生物科技集团股份有限公司（以下简称"公司""本公司"或"大 洋生物"）于 2025 年 8 月 22 日召开第六届董事会第五次会议、第六届监事会第 五次会议，审议通过了《关于继续使用部分闲置募集资金进行现金管理的议案》。 根据《深圳证券交易所上市公司自律监管指引第 1 号—主板上市公司规范运作》 等有关规定，为充分利用公司闲置募集资金，提高资金利用率，在不影响募投项 目建设使用的前提下，公司（含子公司福建舜跃科技股份有限公司，以下简称"福 建舜跃"）使用最高额度不超过 12,000.00 万元（含本数）闲置募集资金进行现金 管理（在此额度内可滚动使用），自董事会审议通过之日起 12 个月之内有效。具 体内容详见公司在《证券时报》《证券日报》和巨潮资讯网（http://www.cninfo.com.cn） 上披露的《关于继续使用部分闲置募集资金进行现金管理的公告》（公告编号 ...

证券代码：003017 证券简称：大洋生物 公告编号：2025-096 浙江大洋生物科技集团股份有限公司 关于实际控制人《一致行动协议》到期解除 并与部分股东重新签订《一致行动协议》暨权益变动的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.本次权益变动是由于浙江大洋生物科技集团股份有限公司（以下简称"公 司"或"大洋生物"）在首次公开发行股票上市前控股股东、实际控制人陈阳贵 先生相继与汪贤玉先生、涂永福先生、仇永生先生、关卫军先生、郝炳炎先生、 陈旭君女士、陈荣芳女士、曾邵平先生签署的《一致行动协议》（以下简称"原 协议"）、《一致行动协议之补充协议》（以下简称"原补充协议"）均已到期 解除，陈阳贵先生和陈旭君女士与汪贤玉先生、仇永生先生、关卫军先生、王国 平先生重新签署了《一致行动协议》（以下简称"新协议"）所致。 原一致行动人涂永福先生于 2023 年 5 月 19 日因病逝世，涂永福先生生前直 接持有的公司股份 2,464,808 股，由其配偶舒玉玲及儿子涂霞丹共同继承，已依 法办理了继承手续，基于继承人个人意愿独立行使 ...

浙江大洋生物科技集团股份有限公司 简式权益变动报告书 上市公司名称：浙江大洋生物科技集团股份有限公司 股票上市地：深圳证券交易所 股票简称：大洋生物 股票代码：003017 信息披露义务人一：陈阳贵 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人二：陈旭君 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人三：汪贤玉 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人四：仇永生 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人五：关卫军 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人六：王国平 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人七：郝炳炎 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人八：陈荣芳 通讯地址：浙江省杭州市建德市大洋镇江南一庄 1 信息披露义务人九：曾邵平 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人十：钱建春 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人十一：陈寿良 通讯地址：浙江省杭州市建德市大洋镇朝阳路22号 信息披露义务人十二：陈寿根 通讯地 ...

Core Viewpoint - The company, Zhejiang Dayang Biotechnology Group Co., Ltd., has released its third-quarter financial report for 2025, ensuring the accuracy and completeness of the information disclosed, with no false records or significant omissions [1][2][7]. Financial Data - The third-quarter financial report has not been audited [6][7]. - The company confirms that there are no adjustments or restatements required for previous accounting data [3]. - There are no non-recurring profit and loss items applicable for the reporting period [3]. Shareholder Information - The company has disclosed information regarding its shareholders, including the total number of ordinary shareholders and the top ten shareholders [4][5]. Other Important Matters - On September 13, 2025, the company announced the completion of the first unlocking period for its employee stock ownership plan, with 60% of the shares eligible for unlocking, amounting to 1,168,218 shares, which represents 1.39% of the total share capital [5]. Board Meeting - The sixth board meeting was held on October 17, 2025, with all nine directors present, and the meeting was conducted in compliance with legal regulations [7][8]. - The board unanimously approved the third-quarter report, affirming that it accurately reflects the company's operational status [8][9].

Core Viewpoint - A significant number of A-share listed companies reported impressive financial results for the third quarter of 2025, indicating strong growth across various sectors [2][3][4]. Group 1: Company Performance Highlights - Chuanjin Nuo reported a revenue of 2.807 billion yuan for the first three quarters of 2025, a year-on-year increase of 27.57%, with a net profit of 304 million yuan, up 175.61% [2]. - Dazhu CNC achieved a revenue of 3.903 billion yuan for the first three quarters, a 66.53% increase, and a net profit of 492 million yuan, up 142.19% [3]. - Alloy Investment's revenue for the first three quarters was 230 million yuan, a 54.61% increase, with a net profit of 7.2581 million yuan, up 124.87% [3]. - Shuangyi Technology reported a revenue of 730 million yuan for the first three quarters, a 15.41% increase, with a net profit of 145 million yuan, up 125.25% [4]. - Jinyi Permanent Magnet achieved a revenue of 5.373 billion yuan for the first three quarters, a 7.16% increase, with a net profit of 515 million yuan, up 161.81% [4]. Group 2: Notable Third Quarter Results - In the third quarter, Chuanjin Nuo's revenue was 1.063 billion yuan, a 27.01% increase, with a net profit of 127 million yuan, up 189.43% [2]. - Dazhu CNC's third-quarter revenue reached 1.521 billion yuan, a 95.19% increase, with a net profit of 228 million yuan, up 281.94% [3]. - Alloy Investment's third-quarter revenue was 65.7118 million yuan, a 21.61% increase, with a net profit of 2.6823 million yuan, up 4985.25% [3]. - Jinyi Permanent Magnet's third-quarter revenue was 1.866 billion yuan, a 12.91% increase, with a net profit of 211 million yuan, up 172.65% [4]. - China Mobile reported a revenue of 794.7 billion yuan for the first three quarters, a 0.4% increase, with a net profit of 115.4 billion yuan, up 4.0% [5].

Core Viewpoint - The article summarizes important announcements from various listed companies in the Shanghai and Shenzhen stock markets, providing insights for investors regarding significant corporate actions and financial performance. Group 1: Corporate Announcements - Wanrun Technology clarified that rumors about an online roadshow and large orders are false, stating no such investor relations activities have occurred recently [4] - DiAo Micro plans to acquire 100% of Rongpai Semiconductor through a combination of share issuance and cash payment, with stock resuming trading on October 21, 2025 [5][6] - Dongtu Technology is planning to issue shares to acquire assets from Beijing Gaoweike Electric Technology, with stock suspension starting October 21, 2025 [7] - Guangsheng Nonferrous Metals announced the absorption merger of two wholly-owned rare earth subsidiaries to enhance management efficiency and reduce operational costs [8] - Shan Shui Technology's actual controller and chairman was subjected to criminal coercive measures, but the company's operations remain normal [9] - Xingchen Technology completed the acquisition of 53.3087% of Shanghai Furui Kun Microelectronics, which will now be a subsidiary [10] - Yiyi Co. is planning to issue shares and cash to acquire assets, with stock suspension since October 14, 2025 [11] - Yintai Group's acquisition of Huatuo Pharmaceutical received antitrust approval, allowing the transaction to proceed [12] Group 2: Financial Performance - China Mobile reported a net profit of 31.1 billion yuan for Q3 2025, a year-on-year increase of 1.4%, with total revenue of 794.7 billion yuan for the first three quarters, up 0.4% [14] - Alloy Investment's Q3 net profit surged by 4985% to 2.68 million yuan, with revenue of 65.71 million yuan, a 21.61% increase [15] - iFlytek's Q3 net profit increased by 202.4% to 172 million yuan, with revenue of 6.078 billion yuan, up 10.02% [16] - Yonghe Co. reported a Q3 net profit of 198 million yuan, a 485.77% increase, with total revenue of 1.34 billion yuan, up 11.42% [17] - Dazhu CNC's Q3 net profit rose by 282% to 228 million yuan, with revenue of 1.521 billion yuan, a 95.19% increase [18] - Dingtong Technology's Q3 net profit grew by 125% to 61.175 million yuan, with year-to-date revenue of 1.156 billion yuan, up 64.45% [20] - Shenneng Power's Q3 net profit increased by 56.69% to 117 million yuan, with total revenue of 459 million yuan, up 33.38% [21] - Runben Co. reported a slight decline in Q3 net profit by 2.89%, totaling 78.52 million yuan, despite a revenue increase of 16.67% [22] - Dayang Bio's Q3 net profit grew by 56.12% to 29.53 million yuan, with revenue of 248 million yuan, up 5.72% [23] - Kaile Co. reported a significant increase in net profit by 159.14% for the first three quarters, totaling 21.63 million yuan [24] - China Shipbuilding expects a net profit increase of 104% to 126% for the first three quarters, estimating between 5.55 billion to 6.15 billion yuan [25] Group 3: Shareholding Changes - Zhejiang Mining's major shareholders plan to reduce their holdings by up to 3% of the company's shares [27] - Blue Arrow Electronics' shareholders intend to reduce their holdings by up to 3% [28] - Jifeng Technology's shareholders plan to reduce their holdings by up to 3% [29] Group 4: Major Contracts - Dash Smart announced a joint bid for a smart transportation project worth 96 million yuan, which represents 3.03% of the company's projected revenue for 2024 [30]

Core Insights - The company reported a revenue of 247,995,033.65 yuan for the third quarter of 2025, reflecting a year-on-year growth of 5.72% [1] - The net profit attributable to shareholders reached 29,531,000.73 yuan, marking a significant year-on-year increase of 48.92% [1] Financial Performance - Revenue for Q3 2025: 247,995,033.65 yuan, up 5.72% year-on-year [1] - Net profit for Q3 2025: 29,531,000.73 yuan, up 48.92% year-on-year [1]